Dixie Lewis

614 total citations
7 papers, 470 citations indexed

About

Dixie Lewis is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dixie Lewis has authored 7 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 1 paper in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dixie Lewis's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (2 papers). Dixie Lewis is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (2 papers). Dixie Lewis collaborates with scholars based in United States. Dixie Lewis's co-authors include Jeffrey S. Miller, Daniel J. Weisdorf, Veronika Bachanová, Michael R. Verneris, Julie Curtsinger, Bin Zhang, Sarah Cooley, Angela Panoskaltsis‐Mortari, Philip B. McGlave and Keli L. Hippen and has published in prestigious journals such as Blood, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Dixie Lewis

7 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dixie Lewis United States 5 411 329 134 59 31 7 470
P. S. A. Becker Germany 6 313 0.8× 259 0.8× 95 0.7× 43 0.7× 11 0.4× 14 379
Marleen Tordoir Netherlands 7 520 1.3× 406 1.2× 151 1.1× 65 1.1× 11 0.4× 7 583
Carmen Choi Germany 7 361 0.9× 245 0.7× 57 0.4× 93 1.6× 22 0.7× 9 440
Anja Waldmann Germany 5 381 0.9× 369 1.1× 41 0.3× 75 1.3× 21 0.7× 6 468
Juergen Kuball United States 3 281 0.7× 275 0.8× 32 0.2× 65 1.1× 13 0.4× 5 387
Gils Roex Belgium 9 162 0.4× 304 0.9× 88 0.7× 166 2.8× 20 0.6× 11 395
Tineke Aarts‐Riemens Netherlands 6 229 0.6× 116 0.4× 76 0.6× 44 0.7× 16 0.5× 11 297
Ariane Thielens France 5 373 0.9× 240 0.7× 52 0.4× 32 0.5× 20 0.6× 7 408
Tanja Kroell Germany 14 373 0.9× 213 0.6× 154 1.1× 79 1.3× 9 0.3× 30 467
Amberly Moreno-Bost United States 4 234 0.6× 258 0.8× 168 1.3× 128 2.2× 39 1.3× 7 365

Countries citing papers authored by Dixie Lewis

Since Specialization
Citations

This map shows the geographic impact of Dixie Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dixie Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dixie Lewis more than expected).

Fields of papers citing papers by Dixie Lewis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dixie Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dixie Lewis. The network helps show where Dixie Lewis may publish in the future.

Co-authorship network of co-authors of Dixie Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Dixie Lewis. A scholar is included among the top collaborators of Dixie Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dixie Lewis. Dixie Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Felices, Martin, Erica D. Warlick, Mark Juckett, et al.. (2021). 444 GTB-3550 tri-specific killer engager TriKE™ drives NK cells expansion and cytotoxicity in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients. Regular and Young Investigator Award Abstracts. A473–A473. 17 indexed citations
4.
Bachanová, Veronika, Zuzan Caycı, Dixie Lewis, et al.. (2020). Initial Clinical Activity of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma. Blood. 136(Supplement 1). 8–8. 31 indexed citations
5.
Bachanová, Veronika, Arthur E. Frankel, Qing Cao, et al.. (2015). Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies. Clinical Cancer Research. 21(6). 1267–1272. 58 indexed citations
6.
Bachanová, Veronika, Sarah Cooley, Todd E. DeFor, et al.. (2014). Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood. 123(25). 3855–3863. 330 indexed citations
7.
Cooley, Sarah, Veronika Bachanová, Melissa A. Geller, et al.. (2011). IL-2 Stimulated Treg Inhibit in Vitro Expansion of Haploidentical Natural Killer (NK) Cells, Which Is Partially Overcome with An IL-2-Diphtheria Toxin Fusion Protein In Vivo,. Blood. 118(21). 3611–3611. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026